In this interview at EADV, Bernstein highlights dupilumab’s impact on urticaria activity in individuals with chronic spontaneous urticaria (CSU).
Jonathan Bernstein, MD
Advertisement
Articles by Jonathan Bernstein, MD
Bernstein also discussed other unmet needs in the field and how his center is working to address them.
Bernstein discussed recent and upcoming research and management of angioedema in patients with urticaria.
Advertisement
Latest Updated Articles
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MDFebruary 14th 2025
Advertisement
Advertisement
Trending on HCPLive
1
Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy
2
Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP
3
First Half 2026 Recap: Dermatology
4
From Red-Cheeked Baby to Bulbous Nose: Rosacea, Start to Finish
5